内分泌検査市場：タイプ、技術、適応症、エンドユーザー別-2025-2030年の世界予測

内分泌検査市場は、2023年に27億9,000万米ドルと評価され、2024年には30億米ドルに達すると予測され、CAGR 8.24％で成長し、2030年には48億6,000万米ドルになると予測されています。

内分泌検査では、さまざまな生理機能の調節に重要な体内のホルモンレベルを分析します。この検査は、ホルモンバランスの乱れや、甲状腺障害、糖尿病、副腎機能障害などの関連疾患の診断に不可欠です。内分泌検査のアプリケーションは、ヘルスケア、医薬品、研究など多くの分野にまたがり、病気のメカニズムや治療効果に関する洞察を提供します。最終用途の範囲には、このような検査が不可欠な病院、診断研究所、研究機関が含まれます。内分泌検査市場は、ホルモン障害の有病率の増加、診断技術の進歩、早期発見の重視の高まりにより成長しています。主な成長促進要因としては、検査機器の技術革新、高齢化、生活習慣病の増加などが挙げられます。現在のビジネスチャンスは、個別化医療への取り組みや、診断ツールへの人工知能の統合という形で存在しており、精度の向上と所要時間の短縮が可能です。しかし、高度な検査法のコスト高、規制上のハードル、発展途上地域におけるアクセスの制限などの課題も残っています。さらに、検査結果のばらつきや標準化された検査の欠如が、市場拡大をさらに複雑にしています。事業成長のためには、非侵襲的検査法の開発、ポイントオブケア検査ソリューション、シームレスなデータ共有と患者エンゲージメントのためのデジタルヘルスプラットフォームの改善など、技術革新の機が熟した分野があります。また、ホルモンの相互作用を細胞レベルで理解することに重点を置いた調査も可能であり、これによって新たな治療介入の道が開けるかもしれないです。市場力学は競争的でダイナミックであり、検査の感度と特異性の向上が絶えず推進されています。この分野に参入する企業は、戦略的パートナーシップ、研究開発への投資、アンメットニーズのある市場の開拓に重点を置き、既存の課題に対処しながらも、拡大する需要を取り込む必要があります。

市場力学：急速に進化する内分泌検査市場の主要市場インサイトを公開

内分泌検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 内分泌疾患の世界の有病率の上昇
  • 内分泌疾患の早期発見の重要性に対する認識の高まり
  • ポイントオブケア検査機器の採用拡大
• 市場抑制要因
  • 内分泌検査に伴う高コスト
• 市場機会
  • アッセイおよび検査法の技術的進歩の拡大
  • ヘルスケア政策と償還制度の改善
• 市場の課題
  • 従来のホルモン測定法への依存

ポーターのファイブフォース：内分泌検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：内分泌検査市場における外部からの影響の把握

外部マクロ環境要因は、内分泌検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析内分泌検査市場における競合情勢の把握

内分泌検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス内分泌検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、内分泌検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨内分泌検査市場における成功への道筋を描く

内分泌検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 内分泌疾患の有病率が世界的に上昇
    • 内分泌疾患の早期発見の重要性に対する認識の高まり
    • ポイントオブケア検査機器の導入拡大
  • 抑制要因
    • 内分泌検査に伴う高額な費用
  • 機会
    • 分析および試験方法における技術的進歩の拡大
    • ヘルスケア政策と医療費償還制度の改善
  • 課題
    • 従来のホルモン検査への依存
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 内分泌検査市場：タイプ別

• コルチゾール検査
• デヒドロエピアンドロステロン硫酸塩（DHEAS）検査
• エストラジオール（E2）検査
• 卵胞刺激ホルモン（FSH）検査
• ヒト絨毛性ゴナドトロピン（hCG）ホルモン検査
• インスリン検査
• 黄体形成ホルモン（LH）検査
• プロゲステロン検査
• プロラクチン検査
• テストステロン検査
• 甲状腺刺激ホルモン（TSH）検査

第7章 内分泌検査市場：技術別

• 臨床化学
• 免疫測定
• タンデム質量分析法

第8章 内分泌検査市場適応症別

• アジソン病
• クッシング病
• 糖尿病
• バセドウ病
• 橋本甲状腺炎

第9章 内分泌検査市場：エンドユーザー別

• 診断センター
• 病院
• 調査機関

第10章 南北アメリカの内分泌検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の内分泌検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの内分泌検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• ACON Laboratories, Inc.
• Agilent Technologies, Inc.
• BioCheck Inc.
• Biogenix Inc. Pvt. Ltd
• bioMerieux SA
• Blueprint Genetics Oy
• Creative Diagnostics
• Danaher Corporation
• Diagnostic Automation/Cortez Diagnostics Inc.
• DiaSorin S.p.A.
• Eagle Biosciences
• EKF Diagnostics Holdings Plc
• Eurofins Analytical Laboratories Inc.
• Getein Biotech, Inc.
• Laboratory Corporation of America Holdings
• MP Biomedicals, LLC
• Ortho-Clinical Diagnostics, Inc.
• Quest Diagnostics Incorporated
• Randox Laboratories Ltd.
• Shenzhen New Industries Biomedical Engineering Co., Ltd.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.
• Trivitron Healthcare

LIST OF FIGURES

• FIGURE 1. ENDOCRINE TESTING MARKET RESEARCH PROCESS
• FIGURE 2. ENDOCRINE TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ENDOCRINE TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ENDOCRINE TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY FOLLICLE STIMULATING HORMONE (FSH) TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY LUTEINIZING HORMONE (LH) TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PROGESTERONE TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PROLACTIN TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TESTOSTERONE TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GRAVES' DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HASHIMOTO THYROIDITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. CANADA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. CHINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. CHINA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. CHINA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. INDIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. INDIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. INDIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. INDIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. PHILIPPINES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. SINGAPORE ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. SOUTH KOREA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. TAIWAN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. THAILAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. THAILAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. THAILAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. THAILAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. VIETNAM ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 117. DENMARK ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. DENMARK ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. DENMARK ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 120. DENMARK ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. EGYPT ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. EGYPT ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. EGYPT ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 124. EGYPT ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. FINLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. FINLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. FINLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. FINLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. FRANCE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. FRANCE ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. FRANCE ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 132. FRANCE ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. GERMANY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. GERMANY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. ISRAEL ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. ITALY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. ITALY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. ITALY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. ITALY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 148. NETHERLANDS ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 152. NIGERIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. NORWAY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. NORWAY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. NORWAY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 156. NORWAY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. POLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. POLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. POLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 160. POLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. QATAR ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. QATAR ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. QATAR ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. QATAR ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 168. RUSSIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 172. SAUDI ARABIA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH AFRICA ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. SPAIN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SPAIN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. SPAIN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 180. SPAIN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 184. SWEDEN ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 188. SWITZERLAND ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. TURKEY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. TURKEY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. TURKEY ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 192. TURKEY ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 196. UNITED ARAB EMIRATES ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 199. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 200. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 202. ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Endocrine Testing Market was valued at USD 2.79 billion in 2023, expected to reach USD 3.00 billion in 2024, and is projected to grow at a CAGR of 8.24%, to USD 4.86 billion by 2030.

Endocrine testing involves the analysis of hormone levels in the body, which are critical in regulating a variety of physiological functions. This testing is essential for diagnosing hormonal imbalances and related conditions such as thyroid disorders, diabetes, and adrenal dysfunction. The application of endocrine testing spans numerous fields, including healthcare, pharmaceuticals, and research, offering insights into disease mechanisms and treatment efficacy. End-use scope covers hospitals, diagnostic laboratories, and research institutions where such testing is integral. The market for endocrine testing is growing due to increasing prevalence of hormonal disorders, advancements in diagnostic technologies, and a rising emphasis on early detection. Key growth drivers include technological innovations in testing equipment, an aging population, and a rising incidence of lifestyle-related diseases. Current opportunities exist in the form of personalized medicine initiatives and the integration of artificial intelligence in diagnostic tools, which can enhance accuracy and reduce turnaround times. However, challenges persist, including high costs of advanced testing methods, regulatory hurdles, and limited access in developing regions. Moreover, variability in test results and the lack of standardized testing further complicate market expansion. For business growth, areas ripe for innovation include the development of non-invasive testing methods, point-of-care testing solutions, and improving digital health platforms for seamless data sharing and patient engagement. Research can also focus on understanding hormone interactions at a cellular level, which may open avenues for novel therapeutic interventions. The nature of the endocrine testing market is competitive and dynamic, with a continual push towards improved sensitivity and specificity of tests. Businesses venturing into this field should focus on strategic partnerships, investing in R&D, and exploring markets with unmet needs to capitalize on growing demand while addressing existing challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endocrine Testing Market

The Endocrine Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of endocrine disorders globally
  • Increased awareness of the importance of early detection of endocrine disorders
  • Growing adoption of point-of-care testing devices
• Market Restraints
  • High cost associated with endocrine tests
• Market Opportunities
  • Expanding technological advancements in assay and testing methods
  • Increasing improvements in healthcare policies and reimbursement systems
• Market Challenges
  • Reliance on conventional hormone assays

Porter's Five Forces: A Strategic Tool for Navigating the Endocrine Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endocrine Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endocrine Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endocrine Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endocrine Testing Market

A detailed market share analysis in the Endocrine Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endocrine Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endocrine Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endocrine Testing Market

A strategic analysis of the Endocrine Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endocrine Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Agilent Technologies, Inc., BioCheck Inc., Biogenix Inc. Pvt. Ltd, bioMerieux SA, Blueprint Genetics Oy, Creative Diagnostics, Danaher Corporation, Diagnostic Automation/Cortez Diagnostics Inc., DiaSorin S.p.A., Eagle Biosciences, EKF Diagnostics Holdings Plc, Eurofins Analytical Laboratories Inc., Getein Biotech, Inc., Laboratory Corporation of America Holdings, MP Biomedicals, LLC, Ortho-Clinical Diagnostics, Inc., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Endocrine Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Insulin Test, Luteinizing Hormone (LH) Test, Progesterone Test, Prolactin Test, Testosterone Test, and Thyroid Stimulating Hormone (TSH) Test.
• Based on Technology, market is studied across Clinical Chemistry, Immunoassay, and Tandem Mass Spectroscopy.
• Based on Indication, market is studied across Addison's Disease, Cushing's Disease, Diabetes, Graves' Disease, and Hashimoto Thyroiditis.
• Based on End-User, market is studied across Diagnostic Centers, Hospitals, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of endocrine disorders globally
    • 5.1.1.2. Increased awareness of the importance of early detection of endocrine disorders
    • 5.1.1.3. Growing adoption of point-of-care testing devices
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with endocrine tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Expanding technological advancements in assay and testing methods
    • 5.1.3.2. Increasing improvements in healthcare policies and reimbursement systems
  • 5.1.4. Challenges
    • 5.1.4.1. Reliance on conventional hormone assays
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Endocrine Testing Market, by Type

• 6.1. Introduction
• 6.2. Cortisol Test
• 6.3. Dehydroepiandrosterone Sulfate (DHEAS) Test
• 6.4. Estradiol (E2) Test
• 6.5. Follicle Stimulating Hormone (FSH) Test
• 6.6. Human Chorionic Gonadotropin (hCG) Hormone Test
• 6.7. Insulin Test
• 6.8. Luteinizing Hormone (LH) Test
• 6.9. Progesterone Test
• 6.10. Prolactin Test
• 6.11. Testosterone Test
• 6.12. Thyroid Stimulating Hormone (TSH) Test

7. Endocrine Testing Market, by Technology

• 7.1. Introduction
• 7.2. Clinical Chemistry
• 7.3. Immunoassay
• 7.4. Tandem Mass Spectroscopy

8. Endocrine Testing Market, by Indication

• 8.1. Introduction
• 8.2. Addison's Disease
• 8.3. Cushing's Disease
• 8.4. Diabetes
• 8.5. Graves' Disease
• 8.6. Hashimoto Thyroiditis

9. Endocrine Testing Market, by End-User

• 9.1. Introduction
• 9.2. Diagnostic Centers
• 9.3. Hospitals
• 9.4. Research Institutes

10. Americas Endocrine Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Endocrine Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Endocrine Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACON Laboratories, Inc.
• 3. Agilent Technologies, Inc.
• 4. BioCheck Inc.
• 5. Biogenix Inc. Pvt. Ltd
• 6. bioMerieux SA
• 7. Blueprint Genetics Oy
• 8. Creative Diagnostics
• 9. Danaher Corporation
• 10. Diagnostic Automation/Cortez Diagnostics Inc.
• 11. DiaSorin S.p.A.
• 12. Eagle Biosciences
• 13. EKF Diagnostics Holdings Plc
• 14. Eurofins Analytical Laboratories Inc.
• 15. Getein Biotech, Inc.
• 16. Laboratory Corporation of America Holdings
• 17. MP Biomedicals, LLC
• 18. Ortho-Clinical Diagnostics, Inc.
• 19. Quest Diagnostics Incorporated
• 20. Randox Laboratories Ltd.
• 21. Shenzhen New Industries Biomedical Engineering Co., Ltd.
• 22. Siemens Healthcare GmbH
• 23. Thermo Fisher Scientific Inc.
• 24. Trivitron Healthcare